toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
Details
   print
  Records Links
Author Gruber, O.; Kaufmann, M.; Köppendörfer, W.; Lackner, K.; Neuhauser, J. doi  openurl
  Title Physics Background of the ASDEX Upgrade Project Type Journal Article
  Year 1984 Publication Journal of Nuclear Materials Abbreviated Journal  
  Volume 121 Issue Pages 407-414  
  Keywords  
  Abstract  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN ISBN Medium  
  Area Expedition Conference  
  Notes Approved no  
  Call Number (up) Serial 1991  
Permanent link to this record
 

 
Author Scarfone, G.; Bergamini, A.; Noli, S.; Villa, A.; Cipriani, S.; Taccagni, G.; Vigano', P.; Candiani, M.; Parazzini, F.; Mangili, G. url  doi
openurl 
  Title Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study Type Observational Study
  Year 2014 Publication Gynecologic Oncology Abbreviated Journal Gynecol Oncol  
  Volume 133 Issue 3 Pages 480-484  
  Keywords Adenocarcinoma, Clear Cell/complications/*epidemiology/pathology; Adult; Age Distribution; Aged; Aged, 80 and over; Carcinoma, Endometrioid/complications/*epidemiology/pathology; Case-Control Studies; Cohort Studies; Endometriosis/*complications; Female; Humans; Middle Aged; Ovarian Neoplasms/complications/*epidemiology/pathology; Prognosis; Retrospective Studies; Clear cell ovarian cancer; Endometriosis; Endometriosis associated ovarian cancer  
  Abstract OBJECTIVE: Endometrioid and clear cell ovarian tumors have been referred to as “endometriosis associated ovarian cancers”. However, very few studies have compared clinical and prognostic features of endometriosis-associated cancers or cancers not associated with endometriosis according to specific histotypes. We have investigated clinical and histological features of the largest published series of clear cell ovarian cancers arising in endometriosis using a retrospective database. METHODS: Seventy three patients with a primary diagnosis of either pure clear cell ovarian cancer and mixed endometrioid-clear cell ovarian cancer have been divided into two groups according to the detection of cancer strictly arising from ovarian endometriosis or not (n=27 and n=46, respectively). Clinical and pathological data have been compared. RESULTS: Patients with clear cell carcinomas arising from endometriosis tend to be significantly younger (51.4+/-10.0 and 58.4+/-11.2years, p=0.02). FIGO stage, laterality, prevalence of pure versus mixed histology, and presence of synchronous endometrial carcinoma were not significantly different between the two groups. Unilateral ovarian involvement was more frequent in cases arising in endometriosis (85% vs 63%, p=0.04). Ascites was not found in any of the endometriosis-associated cancer cases vs 19.5% in patients without endometriosis. The presence of endometriosis did not affect 5-year overall survival rates. CONCLUSIONS: Endometriosis per se does not appear to be associated with a lower stage tumor or to predict prognosis in ovarian clear cell cancers. Unilateral involvement and reduced presence of ascites may be linked to the cystic nature of endometriosis which frequently presents as monolateral and in which associated tumors are more likely to be longer confined to the ovary before spreading.  
  Address Obstetrics and Gynecology Unit, San Raffaele Scientific Institute, Milano, Italy. Electronic address: mangili.giorgia@hsr.it  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 0090-8258 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:24642093 Approved no  
  Call Number (up) ref @ user @ Serial 53990  
Permanent link to this record
 

 
Author 1234 openurl 
  Title 1234 Type Journal Article
  Year 1234 Publication 123 Abbreviated Journal 123  
  Volume 123 Issue 123 Pages 123  
  Keywords 123  
  Abstract 123  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN ISBN Medium  
  Area Expedition Conference  
  Notes Approved no  
  Call Number (up) ref @ user @ Serial 54367  
Permanent link to this record
 

 
Author Garrett, L.A.; Growdon, W.B.; Goodman, A.; Boruta, D.M.; Schorge, J.O.; del Carmen, M.G. url  openurl
  Title Endometriosis-associated ovarian malignancy: a retrospective analysis of presentation, treatment, and outcome Type Journal Article
  Year 2013 Publication The Journal of Reproductive Medicine Abbreviated Journal J Reprod Med  
  Volume 58 Issue 11-12 Pages 469-476  
  Keywords Adenocarcinoma, Clear Cell/diagnosis/pathology/therapy; Adult; Carcinoma, Endometrioid/diagnosis/pathology/therapy; Endometriosis/*complications/epidemiology; Female; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Ovarian Neoplasms/*diagnosis/pathology/therapy; Postmenopause; Premenopause; Retrospective Studies; Survival Rate  
  Abstract OBJECTIVE: To investigate the relationship of age and tumors associated with endometriosis and outcome of different histologies of epithelial ovarian cancer arising from endometriosis. STUDY DESIGN: We identified cases of epithelial ovarian cancers with clear cell, endometrioid, or mixed clear cell and endometrioid histologies from January 2001 to March 2009. Tumors were classified as either “arising in” endometriosis, “associated with” endometriosis or “controls” (not associated with endometriosis). We collected information regarding patient demographics, past medical history, presentation at diagnosis, treatment, and outcome. RESULTS: Of 140 patients identified, 42 (30.0%) had clear cell, 92 (65.7%) had endometrioid, and 6 (4.3%) had mixed. Of those, 28.6% of tumors were associated with endometriosis (n = 40), 37.1% were arising in endometriosis (n = 52), and 34.3% were controls (n = 48). Premenopausal women had tumors that were more likely arising from or associated with endometriosis as compared to tumors in postmenopausal women (p = 0.005). Premenopausal patients were also more likely to present with early stage disease as compared to postmenopausal women (80.4% vs. 63.6%, p = 0.04) and better overall survival (p < 0.008). Survival analyses of the entire cohort showed that improved survival was associated with stage (p < 0.001), grade (p < 0.001), endometrioid histology (p < 0.005), and with tumors associated with or arising in endometriosis (p < 0.04). Multivariate analysis controlling for menopausal status showed the presence of endometriosis was no longer associated with a survival advantage (p = 0.08). CONCLUSION: The association with endometriosis does appear, at least in endometrioid tumors, to provide a survival benefit. Overall, menopausal status, stage, and grade are more powerful variables associated with improved survival.  
  Address Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 0024-7758 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:24568040 Approved no  
  Call Number (up) ref @ user @ Serial 53991  
Permanent link to this record
 

 
Author Kim, H.S.; Kim, T.H.; Chung, H.H.; Song, Y.S. url  doi
openurl 
  Title Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis Type Journal Article
  Year 2014 Publication British Journal of Cancer Abbreviated Journal Br J Cancer  
  Volume 110 Issue 7 Pages 1878-1890  
  Keywords Case-Control Studies; Cohort Studies; Endometriosis/*epidemiology; Female; Humans; Ovarian Neoplasms/*epidemiology; Prognosis; Risk Factors  
  Abstract BACKGROUND: The risk and prognosis of ovarian cancer have not been well established in women with endometriosis. Thus, we investigated the impact of endometriosis on the risk and prognosis for ovarian cancer, and evaluated clinicopathologic characteristics of endometriosis-associated ovarian cancer (EAOC) in comparison with non-EAOC. METHODS: After we searched an electronic search to identify relevant studies published online between January 1990 and December 2012, we found 20 case-control and 15 cohort studies including 444,255 patients from 1,625 potentially relevant studies. In the meta-analysis, ovarian cancer risk by endometriosis and clinicopathologic characteristics were evaluated using risk ratio (RR) or standard incidence ratio (SIR), and prognosis was investigated using hazard ratio (HR) with 95% confidence interval (CI). Heterogeneity was evaluated using Higgins I(2) to select fixed-effect (I(2) </=50%) or random effects models (I(2)>50%), and found no publication bias using funnel plots with Egger's test (P>0.05). Furthermore, we performed subgroup analyses based on study design, assessment of endometriosis, histology, disease status, quality of study and adjustment for potential confounding factors to minimise bias. RESULTS: Endometriosis increased ovarian cancer risk in case-control or two-arm cohort studies (RR, 1.265; 95% CI, 1.214-1.318) and single-arm cohort studies (SIR, 1.797; 95% CI, 1.276-2.531), which were similar in subgroup analyses. Although progression-free survival was not different between EAOC and non-EAOC (HR, 1.023; 95% CI, 0.712-1.470), EAOC was associated with better overall survival than non-EAOC in crude analyses (HR, 0.778; 95% CI, 0.655-0.925). However, progression-free survival and overall survival were not different between the two groups in subgroup analyses. Stage I-II disease, grade 1 disease and nulliparity were more common in EAOC (RRs, 1.959, 1.319 and 1.327; 95% CIs, 1.367-2.807, 1.149-1.514 and 1.245-1.415), whereas probability of optimal debulking surgery was not different between the two groups (RR, 1.403; 95% CI, 0.915-2.152). Furthermore, endometrioid and clear cell carcinomas were more common in EAOC (RRs, 1.759 and 2.606; 95% CIs, 1.551-1.995 and 2.225-3.053), whereas serous carcinoma was less frequent in EAOC than in non-EAOC (RR, 0.733; 95% CI, 0.617-0.871), and there was no difference in the risk of mucinous carcinoma between the two groups (RR, 0.805; 95% CI, 0.584-1.109). These clinicopathologic characteristics were also similar in subgroup analyses. CONCLUSIONS: Endometriosis is strongly associated with the increased risk of ovarian cancer, and EAOC shows favourable characteristics including early-stage disease, low-grade disease and a specific histology such as endometrioid or clear cell carcinoma. However, endometriosis may not affect disease progression after the onset of ovarian cancer.  
  Address 1] Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 101 Daekak-ro Jongno-gu, Seoul 110-744, Republic of Korea [2] Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea [3] Major in Biomodulation, World Class University, Seoul National University, Seoul 151-742, Republic of Korea  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 0007-0920 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:24518590 Approved no  
  Call Number (up) ref @ user @ Serial 53992  
Permanent link to this record
Select All    Deselect All
 |   | 
Details
   print

Save Citations:
Export Records: